rxpertusa logo spacer rxpertusa wings
logo spacer spacer spacer
spacer home
about us
assessment tools
sample consult
contact us

red line

spacer spacer news

The latest Mainline newsletters for the General Public are listed here.


For healthcare professionals we have a Mainline newsletter in a Professional version here.

Printer Friendly


Volume 2 November 15, 2005 Number 11

An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service
Author, Publisher, Editor-in Chief, Typesetter & Printer, Charles S. Feucht,PD,FASCP PharmD candidate

Medication News & Update

Clinical trial results for Abbott's Tricor and Simdax were presented at the American Heart Association conference

 The results from a trial of Abbott's cholesterol treatment Tricor (fenofibrate) failed to meet its primary endpoint of preventing heart attacks and deaths in patients with type 2 diabetes. Separately, the drugmaker reported positive results for injectable drug Simdax (levosimendan) in the treatment of patients with acute decompensated heart failure (ADHF). Data from both trials were presented at the annual meeting of the American Heart Association.



Home ] [ About Us  ] [ Assessment Tools  ] [ Sample Consult  ]
Contact Us  ]

Copyright © www.rxpertusa.com. Designed by PcHousekeeping.com
  spacer spacer